Sol Barer

Dr. Sol J. Barer is a Senior Advisor to Red Cell’s Healthcare Practice. He is a founder and former Chairman, President, COO, and CEO of Celgene (NASDAQ: CELG). Dr. Barer currently serves as Board Chair for Teva Pharmaceuticals (NYSE: TEVA), NexImmune (NASDAQ: NEXI), Centrexion Therapeutics (NASDAQ: CNTX), and Aevi Genomic Medicine (NASDAQ: GNMX). He is also lead director for Contrafect Corp. (NASDAQ: CFRX) and a member of the Board of Directors for 3DBio Therapeutics. Dr. Barer is also the Founding Chair of the Hackensack Meridian Health Center for Discovery & Innovation and is a co-founder of Barer & Son Capital, an investment fund focused on capitalizing early-stage breakthrough biotechnology companies.

Dr. Barer received his PhD in Organic and Physical Chemistry from Rutgers University and his BS in Chemistry from Brooklyn College of the City University of New York.